Cargando…

Trends in the use of antiasthmatic medications in Morocco (1999–2010)

BACKGROUND: Asthma is a big public health problem in Morocco. The drug therapy existing in Morocco is currently insufficient because of the low purchasing power and the low health insurance coverage available to the average citizen in Morocco. In this study we evaluated the consumption of antiasthma...

Descripción completa

Detalles Bibliográficos
Autores principales: Ghanname, Imane, Ahid, Samir, Berrada, Ghizlane, Belaiche, Abdelmjid, Hassar, Mohamed, Cherrah, Yahya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing AG 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3601251/
https://www.ncbi.nlm.nih.gov/pubmed/23519830
http://dx.doi.org/10.1186/2193-1801-2-82
_version_ 1782475741953261568
author Ghanname, Imane
Ahid, Samir
Berrada, Ghizlane
Belaiche, Abdelmjid
Hassar, Mohamed
Cherrah, Yahya
author_facet Ghanname, Imane
Ahid, Samir
Berrada, Ghizlane
Belaiche, Abdelmjid
Hassar, Mohamed
Cherrah, Yahya
author_sort Ghanname, Imane
collection PubMed
description BACKGROUND: Asthma is a big public health problem in Morocco. The drug therapy existing in Morocco is currently insufficient because of the low purchasing power and the low health insurance coverage available to the average citizen in Morocco. In this study we evaluated the consumption of antiasthmatics in Morocco during the period 1999–2010, the classes of used drugs and the generics’ market share. METHODS: We used sales data from the Moroccan subsidiaries of the IMS Health “Intercontinental Marketing Service”. The consumption volume was converted to Defined Daily Doses (DDDs). RESULTS: During 1999–2010, antiasthmatics’s consumption increased from 3.91 to 14.47 DDD per 1000 inhabitants per day. In 2010, the association Beta-2-mimetic-Glucocorticosteroids were the most consumed (8.53 DDD/1000 Inhabitants/day) followed by the short-acting inhaled Beta-2-mimetic (4 DDD/1000 Inhabitants/day) and inhaled Glucocorticosteroids alone accounted for 1.13 DDD/1000 Inhabitants/day. The largest consumption share in volume was held by the short-acting inhaled Beta-2-mimetic (42%) followed by the combination Beta-2-mimetic-Glucocorticosteroids (38%). Between 1999 and 2010, the market for generic antiasthmatics increased from 1.84 to 2.18 DDD/1000 Inhabitants/day. The ratio of the monthly average cost of treatment to the minimum wage in Morocco decreased from 10.8% in 1999 to 7.11% in 2010. CONCLUSION: Antiasthmatics’ consumption in Morocco has undergone significant changes between 1999 and 2010. However, the availability of these drugs expressed as the Average Monthly Expenditure/Guaranteed Minimum Wage ratio improved. Despite this, the use of antiasmathics in Morocco remains low.
format Online
Article
Text
id pubmed-3601251
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Springer International Publishing AG
record_format MEDLINE/PubMed
spelling pubmed-36012512013-03-19 Trends in the use of antiasthmatic medications in Morocco (1999–2010) Ghanname, Imane Ahid, Samir Berrada, Ghizlane Belaiche, Abdelmjid Hassar, Mohamed Cherrah, Yahya Springerplus Research BACKGROUND: Asthma is a big public health problem in Morocco. The drug therapy existing in Morocco is currently insufficient because of the low purchasing power and the low health insurance coverage available to the average citizen in Morocco. In this study we evaluated the consumption of antiasthmatics in Morocco during the period 1999–2010, the classes of used drugs and the generics’ market share. METHODS: We used sales data from the Moroccan subsidiaries of the IMS Health “Intercontinental Marketing Service”. The consumption volume was converted to Defined Daily Doses (DDDs). RESULTS: During 1999–2010, antiasthmatics’s consumption increased from 3.91 to 14.47 DDD per 1000 inhabitants per day. In 2010, the association Beta-2-mimetic-Glucocorticosteroids were the most consumed (8.53 DDD/1000 Inhabitants/day) followed by the short-acting inhaled Beta-2-mimetic (4 DDD/1000 Inhabitants/day) and inhaled Glucocorticosteroids alone accounted for 1.13 DDD/1000 Inhabitants/day. The largest consumption share in volume was held by the short-acting inhaled Beta-2-mimetic (42%) followed by the combination Beta-2-mimetic-Glucocorticosteroids (38%). Between 1999 and 2010, the market for generic antiasthmatics increased from 1.84 to 2.18 DDD/1000 Inhabitants/day. The ratio of the monthly average cost of treatment to the minimum wage in Morocco decreased from 10.8% in 1999 to 7.11% in 2010. CONCLUSION: Antiasthmatics’ consumption in Morocco has undergone significant changes between 1999 and 2010. However, the availability of these drugs expressed as the Average Monthly Expenditure/Guaranteed Minimum Wage ratio improved. Despite this, the use of antiasmathics in Morocco remains low. Springer International Publishing AG 2013-03-05 /pmc/articles/PMC3601251/ /pubmed/23519830 http://dx.doi.org/10.1186/2193-1801-2-82 Text en © Ghanname et al; licensee Springer. 2013 This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Ghanname, Imane
Ahid, Samir
Berrada, Ghizlane
Belaiche, Abdelmjid
Hassar, Mohamed
Cherrah, Yahya
Trends in the use of antiasthmatic medications in Morocco (1999–2010)
title Trends in the use of antiasthmatic medications in Morocco (1999–2010)
title_full Trends in the use of antiasthmatic medications in Morocco (1999–2010)
title_fullStr Trends in the use of antiasthmatic medications in Morocco (1999–2010)
title_full_unstemmed Trends in the use of antiasthmatic medications in Morocco (1999–2010)
title_short Trends in the use of antiasthmatic medications in Morocco (1999–2010)
title_sort trends in the use of antiasthmatic medications in morocco (1999–2010)
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3601251/
https://www.ncbi.nlm.nih.gov/pubmed/23519830
http://dx.doi.org/10.1186/2193-1801-2-82
work_keys_str_mv AT ghannameimane trendsintheuseofantiasthmaticmedicationsinmorocco19992010
AT ahidsamir trendsintheuseofantiasthmaticmedicationsinmorocco19992010
AT berradaghizlane trendsintheuseofantiasthmaticmedicationsinmorocco19992010
AT belaicheabdelmjid trendsintheuseofantiasthmaticmedicationsinmorocco19992010
AT hassarmohamed trendsintheuseofantiasthmaticmedicationsinmorocco19992010
AT cherrahyahya trendsintheuseofantiasthmaticmedicationsinmorocco19992010